<img src="https://publish-01.obsidian.md/access/744ac39d33cabbc297b91373bfcac24d/bin/images/Italy_map.png" alt="Italy" class="page-header-sidebar-image"> Italy has provisions in its legislation relating to the granting of compulsory licences. These can be found in the Intellectual Property Code. There are two possibilities to obtain a compulsory licence, all regulated by the IP Code: - due to lack of exploitation (Art. 70 IPC); - due to dependent patent (Art. 71 IPC, and Art. 81octies IPC regarding biotech and plant varieties pursuant to the implementation of the Biotech Directive). More information can be found [here](https://e-courses.epo.org/wbts_int/CompulsoryLicensing/CL_IT.pdf). ## Compulsory licences Italy has granted compulsory licence for: - [[Finasteride]] - [[Imipenem-Cilastatin]] Italy has been requested to issue a compulsory licence for [[Sumatriptan]] by Fabbrica Italiana Sintetici SpA (FIS). The compulsory licence has not been issued because a voluntary licence and/or data transfer has been agreed as part of a settlement. ## Generic manufacturers Italy has its own generic manufacturer: [Italian Biosimilars Group](https://www.egualia.it/it/biosimilari/chi-siamo.html).